Phase II trial of fulvestrant plus enzalutamide in ER+/HER2− advanced breast cancerAnthony Elias, Jennifer K. Richer, Lyndsey S. Crump et al.|npj Breast Cancer|2023Cited by 16
Abstract P1-17-01: Response of persistent metastatic ER+/Her2- breast cancer treated with fulvestrant plus enzalutamideJennifer K. Richer, Anthony Elias, Nicole S. Spoelstra et al.|Cancer Research|2022Cited by 1